ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in ProMIS Neurosciences Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +2 vs. Q1 2025
- Shares held
- 8.47M
- −841.6K (−9.0%) vs. Q1 2025
- Total value
- $4.10M
- −$2.39M (−36.8%) vs. Q1 2025
- New holders
- 5
- 1 more added
- Sold out
- 3
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $84.3M |
| Q1 2026 | 25 | $78.0M |
| Q4 2025 | 9 | $1.80M |
| Q3 2025 | 23 | $4.25M |
| Q2 2025 | 19 | $4.10M |
| Q1 2025 | 17 | $6.49M |
| Q4 2024 | 17 | $9.21M |
| Q3 2024 | 18 | $12.6M |
| Q2 2024 | 16 | $4.90M |
| Q1 2024 | 16 | $6.46M |
| Q4 2023 | 15 | $3.85M |
| Q3 2023 | 14 | $5.61M |
| Q2 2023 | 13 | $723.8K |
| Q1 2023 | 12 | $889.2K |
| Q4 2022 | 13 | $824.5K |
| Q3 2022 | 13 | $1.13M |
| Q2 2022 | 2 | $468.0K |
| Q1 2022 | 2 | $8.00K |
| Q4 2021 | 2 | $9.00K |
| Q3 2021 | 3 | $14.0K |
| Q2 2021 | 3 | $17.0K |
| Q1 2021 | 3 | $17.0K |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding ProMIS Neurosciences Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Great Point Partners LLC | 2,645,128 | $1.28M | 0.83% | 00.0% | Unchanged |
| Armistice Capital, LLC | 2,137,896 | $1.03M | 0.04% | −196,930−8.4% | Reduced |
| Sphera Funds Management Ltd. | 1,899,297 | $918.9K | 0.24% | −30,000−1.6% | Reduced |
| Ally Bridge Group (NY) LLC | 1,334,428 | $645.6K | 0.54% | −150,271−10.1% | Reduced |
| Allostery Investments LP | 155,720 | $76.3K | 0.97% | −77,983−33.4% | Reduced |
| Citadel Advisors LLC | 63,429 | $31.1K | 0.00% | +63,429 | New |
| Graypoint LLC | 52,833 | $25.6K | 0.00% | +52,833 | New |
| Kingsview Wealth Management, LLC | 31,062 | $15.0K | 0.00% | +31,062 | New |
| Bank of Montreal | 30,366 | $14.9K | 0.00% | 00.0% | Unchanged |
| Fiduciary Trust Co | 28,583 | $13.8K | 0.00% | +10,000+53.8% | Added |
| Ieq Capital, LLC | 26,042 | $12.6K | 0.00% | 00.0% | Unchanged |
| Howard Financial Services, Ltd. | 26,042 | $12.6K | 0.00% | +26,042 | New |
| Commonwealth Equity Services, LLC | 11,447 | $6.00K | 0.00% | +11,447 | New |
| Scotia Capital Inc. | 12,122 | $5.86K | 0.00% | 00.0% | Unchanged |
| Claret Asset Management Corp | 11,330 | $5.00K | 0.00% | – | – |
| Royal Bank of Canada | 5,487 | $3.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,666 | $805 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 133 | $64 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 88 | $42 | 0.00% | 00.0% | Unchanged |
| Altium Capital Management LP | 0 | $0 | 0.00% | −574,248−100.0% | Sold out |
| Heights Capital Management, Inc | 0 | $0 | 0.00% | −18,267−100.0% | Sold out |
| Abound Wealth Management | 0 | $0 | 0.00% | −1−100.0% | Sold out |